Prolonged Response with Enzalutamide in a Prostate Cancer Patient on Hemodialysis
Current therapies in oncology that offer a longer and better quality of life are leading to more cases where cancer and chronic diseases coexist. Enzalutamide, a second-generation anti-androgen agent, was approved by the US Food and Drug Administration (FDA) in 2012 for the treatment of metastatic c...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Rabia Yılmaz
2022-11-01
|
| Sarja: | Journal of Contemporary Medicine |
| Aiheet: | |
| Linkit: | https://dergipark.org.tr/tr/download/article-file/2653132 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|